Minerva Surgical Inc (OTCPK:UTRS)
$ 0.001 0 (0%) Market Cap: 9,000.00 Enterprise Value: 32.44 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Minerva Surgical Inc at UBS Global Healthcare Conference Transcript

May 25, 2022 / 11:45AM GMT
Release Date Price: $50 (+3.31%)
Seth Damergy;UBS;Managing Director

Good morning, everyone. Thank you for getting up bright and early for Day 3 of the UBS Healthcare Conference. I'm Seth Damergy, I'm a Managing Director and I cover medical devices for the bank, and I am pleased to introduce and sit with our next group that's going to present, which is Minerva Surgical. Known team for quite some time and with us today, we have Dave Clapper, CEO; and Joel Jung, CFO of the company.

Minerva, if you're unfamiliar with the company, it's a Nasdaq-listed company focused on Abnormal Uterine Bleeding. The company recently IPO-ed last year and I thought we'd go through some questions over the next 40 minutes. And I'm just going to lead in with them, so thank you again for joining us, gentlemen.

David M. Clapper
Minerva Surgical, Inc. - President, CEO & Director

Thanks and welcome.

Joel R. Jung
Minerva Surgical, Inc. - CFO

Thanks for having us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot